Osaic Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Osaic Holdings's BMY Position: Q3 2026 in Review
Osaic Holdings reduced its Bristol-Myers Squibb (BMY) stake by 7.4% in Q3 2026, selling an estimated $3.97M and leaving 787,980 shares worth $49.3M. The position accounts for 0.06% of the portfolio, ranked #334.
Osaic Holdings first reported a position in BMY in Q1 2020 and has held it in 27 quarters since. The position peaked at $50.2M in Q1 2026. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Osaic Holdings held 787,980 shares of Bristol-Myers Squibb worth $49.3M as of Q3 2026.
- Osaic Holdings sold 62,812 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.97M.
- Bristol-Myers Squibb made up 0.06% of Osaic Holdings's portfolio in Q3 2026, its #334 holding.
- Osaic Holdings first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 27 quarters since.
- Osaic Holdings's Bristol-Myers Squibb position peaked at $50.2M in Q1 2026.
- 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.